Uncategorized Unexpected Growth Seen in Bacteriophage therapy Market 2019 15 Aug 2019 Bacteriophage therapy market report involves an in-depth understanding of Bacteriophage therapy market and highly delivers market insights based on market intelligence studies. Adhering to industry norms, the report comprises chapter…
Uncategorized An ambitious plan to stop the rise of superbugs 9 Aug 2019 Antibiotic resistance is here to stay, but that doesn’t mean we can’t do anything to stop it. A headline that always catches my attention is that antibiotic resistance is on the…
Uncategorized Bacteriophage Market: Global Industry Outlook 5 Aug 2019 Bacteriophage Market: Global Industry Outlook, Industry Share, Market Size, Strategies and Forecast 2018 to 2026 The report provides global and regional forecasting and analysis for the Bacteriophage market. The research provides…
Uncategorized Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections 29 Jul 2019 Romainville and Lyon, France, July 16, 2019 - Pherecydes Pharma and BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announce the signing of a collaboration agreement.This project, called PhagUTI, is a…
Uncategorized Colombian start-up to deliver phage therapy for poultry 27 Jul 2019 Colombia's SciPhage is aiming to secure its first investment round to help commercialization of its bacteriophage therapy.
Uncategorized 15.8% of India’s research work features in world’s top 10 journals 22 Jul 2019 Only 15.8 per cent of the total publications produced by Indian researchers feature in the top 10 journals globally, a government report has revealed. It has emphasised on the dire…
Uncategorized Is a long-lost fix for superbugs hiding in plain sight? 17 Jul 2019 For many years, politicians, patients and drugmakers alike have warned about the risk posed by growing antimicrobial resistance, spurred on by liberal use of antibiotics in farming, and in general…
Uncategorized INVESTORS SUPPORT PHAGE THERAPY: NOVEL APPROACH TO SOLVE THE ANTIBIOTICS CRISIS RECEIVES FURTHER MILLIONS 5 Jul 2019 Vienna (Austria), 27 June 2019: Austrian biotech company PhagoMed Biopharma GmbH successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against…
Uncategorized Alert! Antibiotic resistance rising in Helicobacter strains 1 Jul 2019 A new study has found that Helicobacter pylori, a bacterium that resides in human stomach and causes ulcers, gastritis and stomach cancers, has gained so much resistance to two commonly…
Uncategorized BiomX Licenses Novel Targets for Liver Disease Phage Therapy 29 Jun 2019 NESS ZIONA, Israel, June 11, 2019 /PRNewswire/ -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced it has licensed a new set of bacterial targets from JSR Corporation, for…
